Automatic Compensation of Phase Aberrations in Digital Holographic Microscopy for Ovarian Cancer Cell Drug Sensitivity Survey by Detecting Object-free Regions on Synthetic Difference Image

Frontiers in Optics / Laser Science ◽

10.1364/fio.2020.fw7e.7 ◽

2020 ◽

Author(s):

Leiping Che ◽

Wen Xiao ◽

Feng Pan

Keyword(s):

Ovarian Cancer ◽

Cancer Cell ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Digital Holographic Microscopy ◽

Automatic Compensation ◽

Difference Image ◽

Holographic Microscopy ◽

Phase Aberrations

Download Full-text

Automatic compensation of phase aberrations in digital holographic microscopy for living cells investigation by using spectral energy analysis

Optics & Laser Technology ◽

10.1016/j.optlastec.2013.10.014 ◽

2014 ◽

Vol 57 ◽

pp. 169-174 ◽

Cited By ~ 14

Author(s):

Shuo Liu ◽

Wen Xiao ◽

Feng Pan

Keyword(s):

Energy Analysis ◽

Living Cells ◽

Digital Holographic Microscopy ◽

Spectral Energy ◽

Automatic Compensation ◽

Holographic Microscopy ◽

Phase Aberrations

Download Full-text

Automatic compensation of phase aberrations in digital holographic microscopy based on sparse optimization

APL Photonics ◽

10.1063/1.5115079 ◽

2019 ◽

Vol 4 (11) ◽

pp. 110808 ◽

Cited By ~ 4

Author(s):

Zhenbo Ren ◽

Jianlin Zhao ◽

Edmund Y. Lam

Keyword(s):

Sparse Optimization ◽

Digital Holographic Microscopy ◽

Automatic Compensation ◽

Holographic Microscopy ◽

Phase Aberrations

Download Full-text

Abstract A33: in ovarian cancer cell lines resistant to microtubule-stabilizing agents, expression of IGF2 and ABCB1 is increased and IGF1R inhibition restores drug sensitivity

10.1158/1078-0432.tcme10-a33 ◽

2010 ◽

Author(s):

Jurriaan Brouwer-Visser ◽

Susan Band Horwitz ◽

Gloria S. Huang

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Cancer Cell Lines ◽

Stabilizing Agents ◽

Ovarian Cancer Cell Lines

Download Full-text

Characterisation of theP53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines

International Journal of Cancer ◽

10.1002/(sici)1097-0215(19980911)77:6<913::aid-ijc19>3.0.co;2-1 ◽

1998 ◽

Vol 77 (6) ◽

pp. 913-918 ◽

Cited By ~ 15

Author(s):

Katharine E. Pestell ◽

Clare J. Medlow ◽

Jenny C. Titley ◽

Lloyd R. Kelland ◽

Michael I. Walton

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Cancer Cell Lines ◽

Human Ovarian Cancer ◽

Human Ovarian Cancer Cell ◽

Platinum Drug ◽

Ovarian Cancer Cell Lines

Download Full-text

Abstract POSTER-TECH-1111: High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of emerging drugs

10.1158/1557-3265.ovcasymp14-poster-tech-1111 ◽

2015 ◽

Author(s):

Akira Hirasawa ◽

Astrid Murumägi ◽

Mariliina Arjama ◽

Bhagwan Yadav ◽

John Patrick Mpindi ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

High Throughput ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Drug Repositioning ◽

Resistance Testing ◽

Ovarian Cancer Cell Lines ◽

Therapeutic Possibilities

Download Full-text

Abstract 5384: Systematic high-throughput drug sensitivity and resistance testing (DSRT) of ovarian cancer cell lines indicates novel therapeutic possibilities with existing and emerging drugs

10.1158/1538-7445.am2014-5384 ◽

2014 ◽

Author(s):

Akira Hirasawa ◽

Astrid Murumägi ◽

Mariliina Arjama ◽

Bhagwan Yadav ◽

John Patrick Mpindi ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

High Throughput ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Resistance Testing ◽

Ovarian Cancer Cell Lines ◽

Therapeutic Possibilities ◽

Novel Therapeutic

Download Full-text

Abstract A57: Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines

10.1158/1557-3265.ovca17-a57 ◽

2018 ◽

Author(s):

Pia Roering ◽

Piia Mikkonen ◽

Swapnil Potdar ◽

Krister Wennerberg ◽

Johanna Hynninen ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Drug Sensitivity ◽

Ovarian Cancer Cell ◽

Cancer Cell Lines ◽

Resistance Testing ◽

Primary Ovarian Cancer ◽

Ovarian Cancer Cell Lines

Download Full-text

CD44 splice variants expression correlates with in vitro metastatic potential in ovarian cancer cell lines

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)86250-8 ◽

1998 ◽

Vol 5 (1) ◽

pp. 82A-82A

Author(s):

D GIBBONS ◽

I SANCHOTORRES ◽

C MESONERO ◽

P LEAKEY ◽

J LUDLOW ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Ovarian Cancer Cell ◽

Splice Variants ◽

Metastatic Potential ◽

Cancer Cell Lines ◽

Ovarian Cancer Cell Lines

Download Full-text

ELNCRNA1, A LONG NONCODING RNA TRANSCRIPTIONALLY INDUCED BY OESTROGEN, PROMOTES EPITHELIAL OVARIAN CANCER CELL PROLIFERATION

10.26226/morressier.599bdc7ad462b80296ca15fa ◽

2017 ◽

Author(s):

junjun qiu

Keyword(s):

Ovarian Cancer ◽

Cell Proliferation ◽

Epithelial Ovarian Cancer ◽

Cancer Cell ◽

Long Noncoding Rna ◽

Noncoding Rna ◽

Ovarian Cancer Cell ◽

Cancer Cell Proliferation ◽

Epithelial Ovarian Cancer Cell

Download Full-text

DIFFERENTIAL EXPRESSION OF MTOR COMPONENTS IN ENDOMETRIOSIS AND ENDOMETRIOID OVARIAN CANCER CELL LINE: EFFECTS OF RAPAMYCIN, RESVERATROL AND BEZ-235

10.26226/morressier.597eedbbd462b80296ca1bb1 ◽

2017 ◽

Author(s):

Chatterjee Jayanta

Keyword(s):

Ovarian Cancer ◽

Cell Line ◽

Differential Expression ◽

Cancer Cell ◽

Ovarian Cancer Cell ◽

Ovarian Cancer Cell Line ◽

Cancer Cell Line ◽

Endometrioid Ovarian Cancer

Download Full-text